[FURTHER EVIDENCES OF THE QUALITATIVE ABNORMALITY OF BETA-LIPOPROTEIN IN LIVER DISEASES].
D001796:Blood Protein Disorders; D002761:Cholangitis; D002764:Cholecystitis; D002769:Cholelithiasis; D006505:Hepatitis; D006801:Humans; D006932:Hyperbilirubinemia; D007122:Immunoelectrophoresis; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008103:Liver Cirrhosis; D008107:Liver Diseases; D008111:Liver Function Tests; D008113:Liver Neoplasms; D013301:Streptolysins
D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D013301:Streptolysins
BLOOD LIPIDS; BLOOD PROTEIN DISORDERS; CHOLANGITIS; CHOLECYSTITIS; CHOLELITHIASIS; HEPATITIS; HYPERBILIRUBINEMIA; IMMUNOELECTROPHORESIS; LIPOPROTEINS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; STREPTOLYSIN
NOUVELLES PREUVES DE L'ANOMALIE QUALITATIVE DE LA BETA-LIPOPROT'EINE DANS LES MALADIES DU FOIE.